Inhibits IL-33-mediated ILC2 activation and subsequent Th2 cytokine release via downregulation of the MyD88/NF-κB signaling pathway in ovalbumin-induced asthma in mice (Wang et al., 2018). Here, IL33 is linked to asthma.